CrushSCI.com
141.1Average days
136Median days
71Fastest days
322Longest days
1042025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

188 days

Barriers and Opportunities for Implementing Precision Oncology in Geriatric Cancer Care

Authors
Marcus VetterShow moreShow less
Affiliations
1. Center for Oncology and Hematology, Cantonal Hospital Baselland, Liestal, Switzerland; 2. Medical Faculty, University Basel, Basel, SwitzerlandShow moreShow less
Source PDF DOI Publisher page
160 days

Planned Antihypertensive Deprescribing in Long-Term Care Residents: A Systematic Review of Randomized Evidence

Authors
Guangxiang Jiang; Guang Yang; Yixing Liu; Dongran HanShow moreShow less
Affiliations
1. School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China; 2. School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China; 3. School of Management, Beijing University of Chinese Medicine, Beijing, ChinaShow moreShow less
Source PDF DOI Publisher page
71 days

Opioid Use in Older Adults with Cancer Pain Admitted to an Acute Palliative Care Unit: Does Age Matter? A Secondary Analysis

Authors
Sebastiano Mercadante; Yasmine Grassi; Sofia Settepani; Alessio Lo Cascio; Alessandra CasuccioShow moreShow less
Affiliations
1. Main Regional of Supportive/Palliative Care, La Maddalena Cancer Center, Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, ItalyShow moreShow less
Source PDF DOI Publisher page
322 days

Benzodiazepine Prescription and Use in the Older Adults in Catalonia, Spain from 2018 to 2022: A Drug Utilization Study

Authors
Miliça Paut Kusturica; M. Teresa Peñarrubia-María; Lucy Anne Parker; Sara Mucherino; Enrica Menditto; Valentina Orlando; Ignacio Aznar LouShow moreShow less
Affiliations
1. Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine Novi Sad, University of Novi Sad, Novi Sad, Serbia; 2. Centro de Atención Primaria Bartomeu Fabrés Anglada, Gerencia Territorial Metropolitana Sud, Institut Català de la Salut, Gavà, Spain; 3. Fundació Institut Universitari per a la Recerca a l’Atenció Primaria de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain; 4. Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; 5. Grupo de Investigación en Evaluación de Tecnologías Sanitarias en Atención Primaria y Salud Mental (PRISMA), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain; 6. Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; 7. Departamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández, Sant Joan d’Alacant, Spain; 8. CIRFF-Centro Interdipartimentale di Ricerca in Farmacoeconomia e Farmacoutilizzazione, Università degli Studi di Napoli Federico II, Naples, Italy; 9. Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, Naples, Italy; 10. HealthCare Datalab, Regione Campania, Naples, Italy; 11. Institut d’Investigació Biomèdica de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, SpainShow moreShow less
Source PDF DOI Publisher page
119 days

Intravenous Iron Therapy in Very Old Adults with Heart Failure: A Frailty-Oriented Therapeutic Perspective

Authors
Rémi Esser; Marc Harboun; Marine Larbaneix; Alejandro Mondragon; Marlène Esteban; Christine Farges; Vincenzo Palermo; Nicolas Pages; Sophie Nisse Durgeat; Olivier MaurouShow moreShow less
Affiliations
1. Department of Cardiogeriatrics, Hôpital La Porte Verte, Versailles, France; 2. Department of Cardiology, Hôpital Marie Lannelongue, Le Plessis Robinson, France; 3. Medical Affairs, NP Medical, Bordeaux, FranceShow moreShow less
Source PDF DOI Publisher page
155 days

Long-Term Proton Pump Inhibitor Therapy Is Common Among Older Adults: An 8-Year Finnish Nationwide Register Study

Authors
Leeni Minkkinen; Heini Kari; Fredriikka Nurminen; Juho Leppänen; Hanna KoskinenShow moreShow less
Affiliations
1. Research Unit, The Social Insurance Institution of Finland (Kela), 00250 Helsinki, FinlandShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does DRUGS & AGING take to review a manuscript?

As of 2026-11-18, CrushSCI has 18 complete review records for DRUGS & AGING. The fastest paper went from submission to acceptance in 71 days (Opioid Use in Older Adults with Cancer Pain Admitted to an Acute Palliative Care Unit: Does Age Matter? A Secondary Analysis, received 2026-05-21, accepted 2026-07-31); the slowest took 322 days. The average is 141.1 days and the median is 136 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.